10-103076162-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_017649.5(CNNM2):​c.2310C>T​(p.Ala770Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0939 in 1,606,540 control chromosomes in the GnomAD database, including 9,205 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.088 ( 831 hom., cov: 32)
Exomes 𝑓: 0.094 ( 8374 hom. )

Consequence

CNNM2
NM_017649.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -3.35

Publications

45 publications found
Variant links:
Genes affected
CNNM2 (HGNC:103): (cyclin and CBS domain divalent metal cation transport mediator 2) This gene encodes a member of the ancient conserved domain containing protein family. Members of this protein family contain a cyclin box motif and have structural similarity to the cyclins. The encoded protein may play an important role in magnesium homeostasis by mediating the epithelial transport and renal reabsorption of Mg2+. Mutations in this gene are associated with renal hypomagnesemia. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2011]
CNNM2 Gene-Disease associations (from GenCC):
  • hypomagnesemia, seizures, and intellectual disability 1
    Inheritance: AR, SD, AD Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Illumina, Labcorp Genetics (formerly Invitae)
  • renal hypomagnesemia 6
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • familial primary hypomagnesemia with normocalciuria and normocalcemia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 10-103076162-C-T is Benign according to our data. Variant chr10-103076162-C-T is described in ClinVar as Benign. ClinVar VariationId is 298649.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.35 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.266 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CNNM2NM_017649.5 linkc.2310C>T p.Ala770Ala synonymous_variant Exon 7 of 8 ENST00000369878.9 NP_060119.3 Q9H8M5-1
CNNM2NM_199076.3 linkc.2244C>T p.Ala748Ala synonymous_variant Exon 6 of 7 NP_951058.1 Q9H8M5-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CNNM2ENST00000369878.9 linkc.2310C>T p.Ala770Ala synonymous_variant Exon 7 of 8 1 NM_017649.5 ENSP00000358894.3 Q9H8M5-1
CNNM2ENST00000433628.2 linkc.2244C>T p.Ala748Ala synonymous_variant Exon 6 of 7 2 ENSP00000392875.2 Q9H8M5-2
CNNM2ENST00000475511.1 linkn.364C>T non_coding_transcript_exon_variant Exon 2 of 3 3

Frequencies

GnomAD3 genomes
AF:
0.0879
AC:
13375
AN:
152094
Hom.:
826
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0393
Gnomad AMI
AF:
0.0175
Gnomad AMR
AF:
0.135
Gnomad ASJ
AF:
0.0700
Gnomad EAS
AF:
0.277
Gnomad SAS
AF:
0.185
Gnomad FIN
AF:
0.0746
Gnomad MID
AF:
0.0696
Gnomad NFE
AF:
0.0894
Gnomad OTH
AF:
0.0997
GnomAD2 exomes
AF:
0.124
AC:
29344
AN:
236358
AF XY:
0.124
show subpopulations
Gnomad AFR exome
AF:
0.0343
Gnomad AMR exome
AF:
0.202
Gnomad ASJ exome
AF:
0.0757
Gnomad EAS exome
AF:
0.272
Gnomad FIN exome
AF:
0.0774
Gnomad NFE exome
AF:
0.0851
Gnomad OTH exome
AF:
0.109
GnomAD4 exome
AF:
0.0945
AC:
137411
AN:
1454328
Hom.:
8374
Cov.:
32
AF XY:
0.0972
AC XY:
70236
AN XY:
722632
show subpopulations
African (AFR)
AF:
0.0322
AC:
1075
AN:
33362
American (AMR)
AF:
0.199
AC:
8627
AN:
43350
Ashkenazi Jewish (ASJ)
AF:
0.0753
AC:
1957
AN:
25988
East Asian (EAS)
AF:
0.261
AC:
10297
AN:
39388
South Asian (SAS)
AF:
0.196
AC:
16554
AN:
84574
European-Finnish (FIN)
AF:
0.0773
AC:
4095
AN:
52978
Middle Eastern (MID)
AF:
0.0866
AC:
499
AN:
5762
European-Non Finnish (NFE)
AF:
0.0797
AC:
88353
AN:
1108762
Other (OTH)
AF:
0.0990
AC:
5954
AN:
60164
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
6332
12664
18997
25329
31661
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3388
6776
10164
13552
16940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0880
AC:
13391
AN:
152212
Hom.:
831
Cov.:
32
AF XY:
0.0903
AC XY:
6722
AN XY:
74418
show subpopulations
African (AFR)
AF:
0.0393
AC:
1634
AN:
41556
American (AMR)
AF:
0.135
AC:
2067
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.0700
AC:
243
AN:
3472
East Asian (EAS)
AF:
0.278
AC:
1438
AN:
5180
South Asian (SAS)
AF:
0.184
AC:
887
AN:
4818
European-Finnish (FIN)
AF:
0.0746
AC:
790
AN:
10596
Middle Eastern (MID)
AF:
0.0680
AC:
20
AN:
294
European-Non Finnish (NFE)
AF:
0.0894
AC:
6080
AN:
67992
Other (OTH)
AF:
0.102
AC:
216
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
617
1233
1850
2466
3083
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
160
320
480
640
800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0835
Hom.:
555
Bravo
AF:
0.0906
Asia WGS
AF:
0.195
AC:
677
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Apr 16, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Renal hypomagnesemia 6 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.67
CADD
Benign
1.1
DANN
Benign
0.77
PhyloP100
-3.3
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs943037; hg19: chr10-104835919; COSMIC: COSV63997309; API